| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call to accelerate antiretroviral development for neonates
|
Gaur, Aditya H
|
|
|
|
2 |
p. e65-e67
|
artikel
|
| 2 |
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial
|
Landman, Roland
|
|
|
|
2 |
p. e79-e90
|
artikel
|
| 3 |
Advanced HIV disease and health-related suffering—exploring the unmet need of palliative care
|
Rangaraj, Ajay
|
|
|
|
2 |
p. e126-e133
|
artikel
|
| 4 |
Adverse events associated with abacavir use in HIV-infected children and adolescents: a systematic review and meta-analysis
|
Jesson, Julie
|
|
2016
|
|
2 |
p. e64-e75
nvt p.
|
artikel
|
| 5 |
AIDS activism from the beginning
|
Burki, Talha
|
|
|
|
2 |
p. e78
|
artikel
|
| 6 |
Aiming to end San Francisco's HIV epidemic
|
Kirby, Tony
|
|
|
|
2 |
p. e77-e78
|
artikel
|
| 7 |
A life in balance
|
Stirrups, Robert
|
|
|
|
2 |
p. e89
|
artikel
|
| 8 |
A need to accelerate HIV testing and treatment for children
|
Rujumba, Joseph
|
|
|
|
2 |
p. e69-e71
|
artikel
|
| 9 |
A novel marker of lung-cancer risk in people with HIV
|
Makinson, Alain
|
|
2017
|
|
2 |
p. e53-e55
nvt p.
|
artikel
|
| 10 |
Antiretroviral resistance and management after pre-exposure prophylaxis
|
Tittle, Victoria
|
|
|
|
2 |
p. e84
|
artikel
|
| 11 |
Are reinfections undermining HCV elimination efforts?
|
Chromy, David
|
|
|
|
2 |
p. e68-e69
|
artikel
|
| 12 |
Assessing progress with HIV incidence in national cohorts
|
Karim, Salim S Abdool
|
|
2017
|
|
2 |
p. e56-e58
nvt p.
|
artikel
|
| 13 |
Assisted partner services for HIV case-finding
|
Hogben, Matthew
|
|
2017
|
|
2 |
p. e55-e56
nvt p.
|
artikel
|
| 14 |
Assisted partner services for HIV in Kenya: a cluster randomised controlled trial
|
Cherutich, Peter
|
|
2017
|
|
2 |
p. e74-e82
nvt p.
|
artikel
|
| 15 |
Barriers to paediatric switching to second-line ART
|
Kerr, Stephen J
|
|
|
|
2 |
p. e71-e72
|
artikel
|
| 16 |
Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis
|
Boyd, Mark A
|
|
2015
|
|
2 |
p. e42-e51
nvt p.
|
artikel
|
| 17 |
Brazil sustains HIV response during the COVID-19 pandemic
|
Pereira, Gerson F Mendes
|
|
|
|
2 |
p. e65
|
artikel
|
| 18 |
Can abacavir be used safely in children without HLA testing?
|
Musiime, Victor
|
|
2016
|
|
2 |
p. e58-e59
nvt p.
|
artikel
|
| 19 |
Can cash help eliminate mother-to-child HIV transmission?
|
Pettifor, Audrey
|
|
2016
|
|
2 |
p. e60-e62
nvt p.
|
artikel
|
| 20 |
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
|
Sacks-Davis, Rachel
|
|
|
|
2 |
p. e106-e116
|
artikel
|
| 21 |
Churning in and out of HIV care
|
Nsanzimana, Sabin
|
|
2014
|
|
2 |
p. e58-e59
nvt p.
|
artikel
|
| 22 |
Circulating resistance to first-line HIV drug regimens
|
Iwuji, Collins C
|
|
|
|
2 |
p. e77-e78
|
artikel
|
| 23 |
Commitment issues: PrEP adherence in injecting drug users
|
Page, Kimberly
|
|
2017
|
|
2 |
p. e52-e53
nvt p.
|
artikel
|
| 24 |
Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communities
|
Mulubwa, Chama
|
|
|
|
2 |
p. e81-e92
|
artikel
|
| 25 |
Conditional cash transfers and uptake of and retention in prevention of mother-to-child HIV transmission care: a randomised controlled trial
|
Yotebieng, Marcel
|
|
2016
|
|
2 |
p. e85-e93
nvt p.
|
artikel
|
| 26 |
Conditional economic incentives to improve HIV prevention
|
Pasayan, Mark K U
|
|
|
|
2 |
p. e85
|
artikel
|
| 27 |
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
|
Althoff, Keri N
|
|
|
|
2 |
p. e93-e104
|
artikel
|
| 28 |
Correction to Lancet HIV 2016; 3: e11–12
|
|
|
2016
|
|
2 |
p. e63-
1 p.
|
artikel
|
| 29 |
Crucial but understudied: incentives in HIV research
|
Brown, Brandon
|
|
2018
|
|
2 |
p. e61-e62
|
artikel
|
| 30 |
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial
|
Bekker, Linda-Gail
|
|
2018
|
|
2 |
p. e68-e78
|
artikel
|
| 31 |
Difficult choices for people with HIV in the Donbas
|
Holt, Ed
|
|
|
|
2 |
p. e74
|
artikel
|
| 32 |
Dolutegravir in sub-Saharan Africa: context is crucial
|
Dorward, Jienchi
|
|
|
|
2 |
p. e72-e73
|
artikel
|
| 33 |
Do not repeat mistakes from HIV in COVID-19 response
|
The Lancet HIV,
|
|
|
|
2 |
p. e59
|
artikel
|
| 34 |
Economic incentives for HIV testing by adolescents in Zimbabwe: a randomised controlled trial
|
Kranzer, Katharina
|
|
2018
|
|
2 |
p. e79-e86
|
artikel
|
| 35 |
Educating Russia about HIV/AIDS
|
Holt, Ed
|
|
|
|
2 |
p. e66
|
artikel
|
| 36 |
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis
|
Phillips, Andrew N
|
|
2014
|
|
2 |
p. e85-e93
nvt p.
|
artikel
|
| 37 |
Effect of a clinical decision support system on early action on immunological treatment failure in patients with HIV in Kenya: a cluster randomised controlled trial
|
Oluoch, Tom
|
|
2016
|
|
2 |
p. e76-e84
nvt p.
|
artikel
|
| 38 |
Effect of climate change on the HIV response
|
The Lancet HIV,
|
|
|
|
2 |
p. e63
|
artikel
|
| 39 |
Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study
|
Tan, Jiale
|
|
|
|
2 |
p. e121-e128
|
artikel
|
| 40 |
Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study
|
Punyacharoensin, Narat
|
|
2016
|
|
2 |
p. e94-e104
nvt p.
|
artikel
|
| 41 |
Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial
|
Sierra-Madero, Juan G
|
|
2014
|
|
2 |
p. e60-e67
nvt p.
|
artikel
|
| 42 |
Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort study
|
van der Zee, Ramon P
|
|
|
|
2 |
p. e97-e106
|
artikel
|
| 43 |
Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
|
Lo, Janet
|
|
2015
|
|
2 |
p. e52-e63
nvt p.
|
artikel
|
| 44 |
Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs
|
Reddon, Hudson
|
|
|
|
2 |
p. e128-e136
|
artikel
|
| 45 |
Enhancement of clinical decision making in HIV care in Africa
|
Hamers, Raph L
|
|
2016
|
|
2 |
p. e59-e60
nvt p.
|
artikel
|
| 46 |
Equitable access to PrEP is essential to reap its benefits
|
The Lancet HIV,
|
|
|
|
2 |
p. e69
|
artikel
|
| 47 |
Estimates of the prevalence of undiagnosed HIV among children living with HIV in Eswatini, Lesotho, Malawi, Namibia, Tanzania, Zambia, and Zimbabwe from 2015 to 2017: an analysis of data from the cross-sectional Population-based HIV Impact Assessment surveys
|
Teasdale, Chloe A
|
|
|
|
2 |
p. e91-e101
|
artikel
|
| 48 |
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial
|
Chung, Michael H
|
|
|
|
2 |
p. e104-e112
|
artikel
|
| 49 |
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study
|
Martin, Michael
|
|
2017
|
|
2 |
p. e59-e66
nvt p.
|
artikel
|
| 50 |
Focusing on suicide prevention in people with HIV
|
Wang, Yuanyuan
|
|
|
|
2 |
p. e71-e72
|
artikel
|
| 51 |
Forgiveness of an intermittent HIV treatment strategy
|
Parienti, Jean-Jacques
|
|
|
|
2 |
p. e68-e69
|
artikel
|
| 52 |
For the greatest impact, end caps on PrEP access now
|
The Lancet HIV,
|
|
|
|
2 |
p. e67
|
artikel
|
| 53 |
Global PrEP roll-out: recommendations for programmatic success
|
Rivet Amico, K
|
|
|
|
2 |
p. e137-e140
|
artikel
|
| 54 |
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study
|
Smit, Colette
|
|
|
|
2 |
p. e96-e105
|
artikel
|
| 55 |
HIV and reincarceration: time for a comprehensive approach
|
Westergaard, Ryan P
|
|
2014
|
|
2 |
p. e54-e55
nvt p.
|
artikel
|
| 56 |
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial
|
Korthuis, P Todd
|
|
|
|
2 |
p. e67-e76
|
artikel
|
| 57 |
HIV epidemiology in the WHO Eastern Mediterranean region: a multicountry programme review
|
Mugisa, Bridget
|
|
|
|
2 |
p. e112-e119
|
artikel
|
| 58 |
HIV-free generation within reach for Botswana
|
Adepoju, Paul
|
|
|
|
2 |
p. e76-e77
|
artikel
|
| 59 |
HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and use
|
Vekemans, Johan
|
|
|
|
2 |
p. e141-e148
|
artikel
|
| 60 |
HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study
|
Meyer, Jaimie P
|
|
2014
|
|
2 |
p. e77-e84
nvt p.
|
artikel
|
| 61 |
HIV in Thai men who have sex with men: a sustained emergency
|
Sullivan, Patrick Sean
|
|
2015
|
|
2 |
p. e38-e39
nvt p.
|
artikel
|
| 62 |
HIV surveys in older adults: better data, better health
|
Vollmer, Sebastian
|
|
2015
|
|
2 |
p. e40-e41
nvt p.
|
artikel
|
| 63 |
HIV transmission in MSM: considerations for PrEP scale-up
|
Arnold, Emily A
|
|
2016
|
|
2 |
p. e62-e63
nvt p.
|
artikel
|
| 64 |
Home HIV testing and counselling: answers raising questions
|
Kimmel, April D
|
|
2014
|
|
2 |
p. e52-e53
nvt p.
|
artikel
|
| 65 |
Homophobia in the provision of sexual health care in the UK
|
Kohli, Manik
|
|
|
|
2 |
p. e125-e130
|
artikel
|
| 66 |
Hostile health-care environment could increase migrants' risk of HIV and prevent access to vital services
|
Finnerty, Fionnuala
|
|
|
|
2 |
p. e76
|
artikel
|
| 67 |
How do we preserve health among adults living with HIV?
|
Rasmussen, Line D
|
|
|
|
2 |
p. e69-e70
|
artikel
|
| 68 |
How do we prevent anal cancer in people living with HIV?
|
Stier, Elizabeth Ann
|
|
|
|
2 |
p. e71-e73
|
artikel
|
| 69 |
Identifying HIV care continuum gaps with verbal autopsy
|
Bogoch, Isaac I
|
|
2018
|
|
2 |
p. e65-e67
|
artikel
|
| 70 |
Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial
|
Nunes, Marta C
|
|
|
|
2 |
p. e91-e103
|
artikel
|
| 71 |
Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study
|
Sigel, Keith
|
|
2017
|
|
2 |
p. e67-e73
nvt p.
|
artikel
|
| 72 |
Imperfect progress: treatment options for opioid dependence
|
Sabin, Keith M
|
|
|
|
2 |
p. e60-e61
|
artikel
|
| 73 |
Implementation of PrEP in Latin America
|
Guerrero-Torres, Lorena
|
|
|
|
2 |
p. e70-e71
|
artikel
|
| 74 |
Inadequate HIV care after incarceration: case closed
|
Wohl, David Alain
|
|
2018
|
|
2 |
p. e64-e65
|
artikel
|
| 75 |
Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration
|
|
|
|
|
2 |
p. e105-e115
|
artikel
|
| 76 |
Influenza vaccine in pregnant women with HIV: are we there?
|
Nachman, Sharon
|
|
|
|
2 |
p. e76-e77
|
artikel
|
| 77 |
Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study
|
Barnabas, Ruanne V
|
|
2014
|
|
2 |
p. e68-e76
nvt p.
|
artikel
|
| 78 |
Insights on COVID-19 mortality and HIV from South Africa
|
Justman, Jessica E
|
|
|
|
2 |
p. e67-e68
|
artikel
|
| 79 |
Integrating substance use and mental health services
|
Bao, Yanping
|
|
|
|
2 |
p. e74-e75
|
artikel
|
| 80 |
IPV prevention must be integrated into HIV care
|
Jewkes, Rachel
|
|
|
|
2 |
p. e73-e74
|
artikel
|
| 81 |
Mexico's fragmented health system as a barrier to HIV care
|
Sierra-Madero, Juan G
|
|
|
|
2 |
p. e74-e75
|
artikel
|
| 82 |
Micro-elimination of HIV and HCV co-infection
|
Dusheiko, Geoff
|
|
|
|
2 |
p. e61-e62
|
artikel
|
| 83 |
Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study
|
Marcy, Olivier
|
|
2018
|
|
2 |
p. e87-e95
|
artikel
|
| 84 |
Mother-to-child transmission must remain on the agenda
|
The Lancet HIV,
|
|
2018
|
|
2 |
p. e59
|
artikel
|
| 85 |
No excuses left to delay opioid agonist treatment roll-out
|
Malyuta, Ruslan
|
|
|
|
2 |
p. e80-e81
|
artikel
|
| 86 |
Nurse-led PrEP provision at 56 Dean Street
|
Whitlock, Gary
|
|
|
|
2 |
p. e81
|
artikel
|
| 87 |
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
|
Antoni, Guillemette
|
|
|
|
2 |
p. e113-e120
|
artikel
|
| 88 |
On-demand PrEP efficacy: forgiveness or timely dosing
|
Parienti, Jean-Jacques
|
|
|
|
2 |
p. e79-e80
|
artikel
|
| 89 |
Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial
|
Bekker, Adrie
|
|
|
|
2 |
p. e86-e95
|
artikel
|
| 90 |
Paediatric HIV: the law of amplified returns
|
The Lancet HIV,
|
|
2016
|
|
2 |
p. e57-
1 p.
|
artikel
|
| 91 |
Positive Impact Health Centres—Atlanta, GA, USA
|
Kirby, Tony
|
|
|
|
2 |
p. e88
|
artikel
|
| 92 |
Potential health benefits of integrated screening strategies for alcohol, tobacco, other substance use, depression, anxiety, and chronic pain among people living with HIV in the USA: a mathematical modelling study
|
Bershteyn, Anna
|
|
|
|
2 |
p. e118-e125
|
artikel
|
| 93 |
Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study
|
Loeliger, Kelsey B
|
|
2018
|
|
2 |
p. e96-e106
|
artikel
|
| 94 |
Pre-exposure prophylaxis in the era of emerging methods for men who have sex with men in the USA: the HIV Prevention Cycle of Care model
|
Mansergh, Gordon
|
|
|
|
2 |
p. e134-e142
|
artikel
|
| 95 |
PrEP use falling short in African American and Hispanic MSM
|
Kirby, Tony
|
|
|
|
2 |
p. e86-e87
|
artikel
|
| 96 |
Preventing tuberculosis-related death in children with HIV
|
Tootla, Hafsah Deepa
|
|
2018
|
|
2 |
p. e62-e64
|
artikel
|
| 97 |
Prophylactic HIV-1 vaccine trials: past, present, and future
|
Nkolola, Joseph P
|
|
|
|
2 |
p. e117-e124
|
artikel
|
| 98 |
Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua
|
Dunk, Caroline E
|
|
|
|
2 |
p. e120-e129
|
artikel
|
| 99 |
Reaching the 90-90-90 target: lessons from HIV self-testing
|
Celum, Connie
|
|
|
|
2 |
p. e68-e69
|
artikel
|
| 100 |
Refugees from Ukraine: children and adolescents with HIV in Germany
|
Feiterna-Sperling, Cornelia
|
|
|
|
2 |
p. e81-e82
|
artikel
|
| 101 |
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
|
Phillips, Andrew N
|
|
|
|
2 |
p. e116-e127
|
artikel
|
| 102 |
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study
|
Nel, Annalene
|
|
|
|
2 |
p. e77-e86
|
artikel
|
| 103 |
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
|
Orkin, Chloe
|
|
|
|
2 |
p. e75-e85
|
artikel
|
| 104 |
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study
|
Baeten, Jared M
|
|
|
|
2 |
p. e87-e95
|
artikel
|
| 105 |
Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study
|
Veloso, Valdiléa G
|
|
|
|
2 |
p. e84-e96
|
artikel
|
| 106 |
Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention
|
Rowan, Sarah E
|
|
|
|
2 |
p. e114-e120
|
artikel
|
| 107 |
San Francisco AIDS Foundation
|
Kirby, Tony
|
|
|
|
2 |
p. e79
|
artikel
|
| 108 |
Second-line antiretroviral therapy and the human factor
|
Pérez-Valero, Ignacio
|
|
2015
|
|
2 |
p. e34-e35
nvt p.
|
artikel
|
| 109 |
Shear stress of inequality
|
Mitchell, Fiona
|
|
|
|
2 |
p. e80
|
artikel
|
| 110 |
Should everyone ageing with HIV take a statin?
|
Justice, Amy
|
|
2015
|
|
2 |
p. e36-e37
nvt p.
|
artikel
|
| 111 |
Stigma reduction: an essential ingredient to ending AIDS by 2030
|
Nyblade, Laura
|
|
|
|
2 |
p. e106-e113
|
artikel
|
| 112 |
Stigma reduction interventions in people living with HIV to improve health-related quality of life
|
Andersson, Galit Zeluf
|
|
|
|
2 |
p. e129-e140
|
artikel
|
| 113 |
Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study
|
Justman, Jessica
|
|
2017
|
|
2 |
p. e83-e92
nvt p.
|
artikel
|
| 114 |
Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006–13: an observational study
|
van Griensven, Frits
|
|
2015
|
|
2 |
p. e64-e70
nvt p.
|
artikel
|
| 115 |
Thank you to The Lancet HIV's clinical and statistical peer reviewers in 2021
|
The Lancet HIV Editors,
|
|
|
|
2 |
p. e72-e75
|
artikel
|
| 116 |
Thank you to The Lancet HIV's statistical and peer reviewers in 2022
|
The Lancet HIV Editors,
|
|
|
|
2 |
p. e78-e80
|
artikel
|
| 117 |
Thank you to The Lancet HIV's statistical and peer reviewers in 2023
|
The Lancet HIV Editors,
|
|
|
|
2 |
p. e71-e73
|
artikel
|
| 118 |
The best place for doravirine
|
Mussini, Cristina
|
|
|
|
2 |
p. e64-e65
|
artikel
|
| 119 |
The costs of inaction on PrEP
|
The Lancet HIV,
|
|
2017
|
|
2 |
p. e51-
1 p.
|
artikel
|
| 120 |
The effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade: a pooled analysis of nationally representative surveys in sub-Saharan Africa
|
Kuchukhidze, Salome
|
|
|
|
2 |
p. e107-e117
|
artikel
|
| 121 |
The HIV vaccine quest: ethical and implementation challenges
|
Rennie, Stuart
|
|
|
|
2 |
p. e70-e71
|
artikel
|
| 122 |
The law and HIV
|
The Lancet HIV,
|
|
2017
|
|
2 |
p. e51-
1 p.
|
artikel
|
| 123 |
The long shadows of past mistakes
|
The Lancet HIV,
|
|
2015
|
|
2 |
p. e33-
1 p.
|
artikel
|
| 124 |
The path to elimination of vertical transmission of HIV
|
The Lancet HIV,
|
|
|
|
2 |
p. e67
|
artikel
|
| 125 |
Therapeutic CCR5 blockade illuminates IRIS pathogenesis
|
French, Martyn A
|
|
2014
|
|
2 |
p. e50-e51
nvt p.
|
artikel
|
| 126 |
The syndemic threat of food insecurity and HIV
|
The Lancet HIV,
|
|
|
|
2 |
p. e75
|
artikel
|
| 127 |
Time for the UK to get ready for PrEP
|
The Lancet HIV,
|
|
2014
|
|
2 |
p. e49-
1 p.
|
artikel
|
| 128 |
Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data
|
Jassat, Waasila
|
|
|
|
2 |
p. e96-e105
|
artikel
|
| 129 |
Trends in suicide mortality among people with HIV after diagnosis during 2012–18: a retrospective, national cohort study in China
|
Chen, Fangfang
|
|
|
|
2 |
p. e102-e111
|
artikel
|
| 130 |
UK and US militaries update HIV policies
|
Burki, Talha
|
|
|
|
2 |
p. e83
|
artikel
|
| 131 |
Universal health care needed to end HIV epidemic in the USA
|
Goedel, William C
|
|
|
|
2 |
p. e63-e64
|
artikel
|
| 132 |
Update on injectable antiretrovirals at HIV Glasgow
|
Waters, Laura
|
|
|
|
2 |
p. e75-e77
|
artikel
|
| 133 |
Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps
|
Naidoo, Anushka
|
|
|
|
2 |
p. e130-e138
|
artikel
|
| 134 |
What do we say about condoms in 2019?
|
Ard, Kevin L
|
|
|
|
2 |
p. e82-e83
|
artikel
|
| 135 |
Which strategy for ART in resource-limited settings?
|
Laurent, Christian
|
|
2014
|
|
2 |
p. e56-e57
nvt p.
|
artikel
|
| 136 |
Working towards HIV prevention choices for women
|
van de Wijgert, Janneke
|
|
2018
|
|
2 |
p. e60-e61
|
artikel
|
| 137 |
You'll never forget your first time
|
Ranscombe, Peter
|
|
|
|
2 |
p. e90
|
artikel
|
Tijdschrift beschrijving